4,108 results match your criteria: "Tricuspid Valve Disease Imaging"
Quant Imaging Med Surg
December 2024
Zhejiang-Ireland Joint Laboratory for Precision Diagnosis and Treatment of Valvular Heart Diseases, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Background: Accurate assessment of aortic root is crucial for the preprocedural planning of transcatheter aortic valve replacement (TAVR). A variety software is emerging for the semiautomated or automated measurements during TAVR planning. This study evaluated a new deep-learning (DL) tool based on cardiac computed tomography angiography (CCTA) for fully automatic assessment of aortic root.
View Article and Find Full Text PDFKyobu Geka
November 2024
Department of Thoracic and Cardiovascular Surgery, Hirosaki University, Hirosaki, Japan.
A 75-year-old man with mitral regurgitation (MR) and tricuspid regurgitation (TR) caused by Barlow 's disease was referred to our hospital. He had a history of persistent atrial fibrillation. Echocardiography showed severe MR with bi-leaflet billowing and functional TR.
View Article and Find Full Text PDFJACC Cardiovasc Interv
December 2024
Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China. Electronic address:
Background: Conservative treatments for tricuspid regurgitation (TR) frequently yield suboptimal outcomes. Transcatheter interventions provide a new therapeutic avenue, with ongoing assessments of safety and effectiveness.
Objectives: The TriStar (Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip™ Transcatheter Annuloplasty System) study investigated 1-year outcomes of the K-Clip transcatheter tricuspid annuloplasty system in treating patients with severe functional TR.
JACC Cardiovasc Interv
December 2024
Division of Cardiology, Department of Medicine, Glen Hospital, McGill University Health Center, Montreal, Quebec, Canada. Electronic address:
Despite the challenges associated with periprocedural imaging, transcatheter tricuspid valve interventions have shown important impact on outcomes. A comprehensive understanding of the anatomy of the right heart and surrounding structures is crucial. One way to optimize these interventions is by identifying the optimal fluoroscopic viewing angles along the S-curve of the tricuspid valve.
View Article and Find Full Text PDFKyobu Geka
September 2024
Department of Pediatric Cardiovascular Surgery, JCHO Kyushu Hospital, Kitakyushu, Japan.
Echocardiography
December 2024
Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.
Eur J Cardiothorac Surg
November 2024
Department of Cardiology, St Thomas' Hospital, London, UK.
Objectives: Right ventricular-to-pulmonary artery coupling has been associated with outcomes in mitral regurgitation treated by transcatheter approaches. We evaluated right ventricular-to-pulmonary artery coupling as a predictor of survival and postoperative length of hospital stay (LOS) in patients with mitral regurgitation undergoing mitral valve surgery.
Methods: In this retrospective analysis (median follow-up: 5.
Clin Cardiol
December 2024
Department of Internal Medicine II, Ulm University Heart Center, Ulm, Baden-Württemberg, Germany.
Eur J Heart Fail
November 2024
Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
Aims: Right ventricular reverse remodelling (RVRR) is linked to improved survival in patients with severe tricuspid regurgitation (TR) and right-sided heart failure who underwent interventional treatment. However, the role of residual TR on RVRR remains unclear. In this analysis the impact of residual TR on RVRR after interventional TR treatment, which was validated by two independent cohorts at four sites using echocardiography or cardiac magnetic resonance (CMR) imaging, was investigated.
View Article and Find Full Text PDFJ Cardiovasc Imaging
November 2024
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Rev Med Inst Mex Seguro Soc
November 2024
Centro Médico ABC Campus, Servicio, Área o Departamento. Cuidad de México, México.
Ann Pediatr Cardiol
October 2024
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Partial cavopulmonary shunt is an established procedure for patients with abnormal right ventricular (RV) physiology. Late failure of the Glenn shunt is usually due to further progression of the primary disease process. However, there may be surprises, as in our patient.
View Article and Find Full Text PDFBMJ Case Rep
November 2024
Medical Student, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, Maharashtra, India.
Rev Assoc Med Bras (1992)
November 2024
Dr. Suat Seren Chest Diseases and Thoracic Surgery Research and Education Hospital - İzmir, Turkey.
Objective: Vascular endothelial growth factor is a signaling protein created by cells performing important bodily functions. Vascular endothelial growth factor is abundant in the lung, and plasma levels are elevated in patients with severe pulmonary arterial hypertension. An association between soluble urokinase plasminogen activator receptor, an inflammatory biomarker, and soluble urokinase plasminogen activator receptor levels and interstitial pulmonary and vascular involvement (e.
View Article and Find Full Text PDFFront Cardiovasc Med
October 2024
Department of Cardiology, University Hospital Heart Center Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Neuruppin, Germany.
Background: Severe tricuspid regurgitation is a progressive disease with an unfavourable prognosis. In recent years there have been extraordinary gains in knowledge through both clinical and basic scientific work. We performed a bibliometric analysis on tricuspid regurgitation with a focus on imaging techniques and treatment approaches and to identify scientific milestones and emerging research trends.
View Article and Find Full Text PDFSci Rep
November 2024
Ultrasound in Cardiac Electrophysiology and Biomechanics Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cardiovascular Disease, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.
Transthoracic echocardiography (TTE) is widely recognized as one of the principal modalities for diagnosing tricuspid regurgitation (TR). The diagnostic procedures associated with conventional methods are intricate and labor-intensive, with human errors leading to measurement variability, with outcomes critically dependent on the operators' diagnostic expertise. In this study, we present an innovative assessment methodology for evaluating TR severity utilizing an end-to-end deep learning system.
View Article and Find Full Text PDFEur J Cardiothorac Surg
November 2024
Cardiovascular Imaging Unit, Cardio-Thoracic-Vascular Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
BMJ Case Rep
November 2024
Division of Cardiology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
Echocardiography
November 2024
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China.
Ann Biomed Eng
November 2024
Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Purpose: Finite element simulations are an enticing tool to evaluate heart valve function; however, patient-specific simulations derived from 3D echocardiography are hampered by several technical challenges. The objective of this work is to develop an open-source method to enforce matching between finite element simulations and in vivo image-derived heart valve geometry in the absence of patient-specific material properties, leaflet thickness, and chordae tendineae structures.
Methods: We evaluate FEBio Finite Element Simulations with Shape Enforcement (FINESSE) using three synthetic test cases considering a range of model complexity.
Arch Cardiovasc Dis
October 2024
Cardiology, Bichat Hospital, AP-HP, 75018 Paris, France; UMRS 1148, Inserm, 75018 Paris, France; Université Paris Cité, 75006 Paris, France.
Background: In patients with significant tricuspid regurgitation, cardiac magnetic resonance imaging (CMR) is the preferred method for the evaluation of right ventricular function and volumes. However validated thresholds are lacking.
Aim: The aim of this study was to evaluate CMR assessment of right ventricular volumes in patients with significant (moderate or severe) tricuspid regurgitation, and to define its association with outcomes.
J Am Coll Cardiol
October 2024
Division of Cardiology, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA; Cardiovascular Research Foundation, New York, New York, USA.
J Am Coll Cardiol
October 2024
Cardiovascular Research Foundation, New York, New York, USA; St Francis Hospital, Roslyn, New York, USA.
Background: Severe tricuspid regurgitation (TR) often causes substantial impairment in patient-reported health status (ie, symptoms, physical and social function, and quality of life), which may improve with transcatheter tricuspid valve replacement (TTVR).
Objectives: We performed an in-depth analysis of health status of patients enrolled in the TRISCEND (Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device) II pivotal trial to help quantify the benefit of intervention to patients.
Methods: The TRISCEND II pivotal trial randomized 400 patients with symptomatic and severe or greater TR 2:1 to TTVR with the EVOQUE tricuspid valve replacement system plus optimal medical therapy (OMT) or OMT alone.
Echocardiography
November 2024
IRCCS Humanitas Research Hospital, Via Alessandro Manzoni, Milano, Italy.
J Am Heart Assoc
November 2024
Department of Cardiology West China Hospital, Sichuan University Chengdu People's Republic of China.